Learning from Novartis: India in the quid pro quo world
The Novartis case shone a spotlight on India’s unique patent system. Deepa Kachroo Tiku and Taapsi Johri Singh explore the questions and uncertainties raised by the controversial decision
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: